Loading clinical trials...
Loading clinical trials...
A 12-month Open-label, Randomized, Multicenter, Sequential Cohort, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Corticosteroids in de Novo Adult Renal Transplant Recipients
Conditions
Interventions
AEB071
Locations
41
United States
USC Medical Center
Los Angeles, California, United States
University of California San Diego
San Diego, California, United States
California Pacific Medical Center
San Francisco, California, United States
UCSF
San Francisco, California, United States
University of Colorado Health Science Center
Denver, Colorado, United States
Lifelink, Inc.
Tampa, Florida, United States
Start Date
January 1, 2007
Primary Completion Date
May 1, 2008
Last Updated
December 22, 2020
NCT05753930
NCT04128189
NCT04870437
NCT07415421
NCT06958796
NCT07294547
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions